Filing Details

Accession Number:
0001140361-10-024497
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-07 13:00:00
Reporting Period:
2010-06-03
Filing Date:
2010-06-07
Accepted Time:
2010-06-07 16:56:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
350907 Thoratec Corp THOR Electromedical & Electrotherapeutic Apparatus (3845) 942340464
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218701 Daniel J Cole 6035 Stoneridge Drive
Pleasanton CA 94588
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-03 1,875 $15.45 51,875 No 4 M Direct
Common Stock Acquisiton 2010-06-03 1,875 $18.99 53,750 No 4 M Direct
Common Stock Disposition 2010-06-03 860 $44.29 52,890 No 4 S Direct
Common Stock Disposition 2010-06-03 140 $44.91 52,750 No 4 S Direct
Common Stock Disposition 2010-06-04 1,480 $43.66 51,270 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-06-03 1,875 $0.00 1,875 $15.45
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-06-03 1,875 $0.00 1,875 $18.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-08-18 2010-08-18 No 4 M Direct
0 2005-11-17 2010-11-17 No 4 M Direct
Footnotes
  1. This option vested 100% on the grant date.
  2. This option was granted pursuant to the Company's Incentive Stock Plan with no payment received for the option.
  3. Options exercised and shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on May 3, 2010, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended.
  4. This transaction was executed in multiple trades in prices ranging from $43.60 to $44.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades in prices ranging from $44.60 to $45.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades in prices ranging from $43.605 to $43.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.